Member access

4-Traders Homepage  >  News


Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Burzynski Clinic Presents Over Five Years Survival Data From Phase II Trials of ANP for Inoperable Brain Tumors at the Congress

11/15/2013 | 09:34pm US/Eastern

The Burzynski Clinic (BC) announced today that it made a keynote speaker presentation at the 2nd Annual Congress of Asia-Pacific Academy of Anti-Aging Medicine in Beijing, China. Based on the presentation in Beijing, a total of 401 eligible patients (patients who received over 28 days of treatment) with advanced inoperable brain tumors have been treated with antineoplaston A10 and antineoplastons AS2-1 therapy (ANP) in phase II studies. Most of the patients (87%) were diagnosed with high-grade tumors and the remaining patients were diagnosed with low-grade tumors. The patients were diagnosed by pathologists not associated with BC and objective responses were verified by Central Radiology Review. The group of 77 patients (19%) survived over five years from the treatment start. Of particular interest were results in patients with brainstem gliomas. The group of 17 patients with brainstem glioma underwent the treatment and 65% of these patients survived over five years. An additional group of 42 patients diagnosed with diffuse intrinsic pontine glioma (DIPG) have been treated and a total of 19% survived over five years.

The quality of survival is very good and there is no long-term toxicity related to ANP.

These clinical results are very encouraging, since they describe a positive ANP effect on some of the worst malignancies in the entire oncology field, but they will require FDA approval.

Burzynski Clinic is committed to developing treatments for cancer based on genomic and epigenomic principles.

Forward-looking statements in this release are made pursuant to the safe harbor provisions of the federal securities laws. Information contained in forward-looking statements is based on current expectations and is subject to change, and future events may differ materially from those discussed herein due to a number of factors, including, but not limited to, risks and uncertainties related to the clinic's ability to use Antineoplastons A10 and AS2-1. Burzynski Clinic does not undertake to update any such forward-looking statements or to publicly announce developments or events relating to the matters described herein.

For Burzynski Clinic
Carolyn Powers, 713-335-5664

© Business Wire 2013
Recommend :
React to this article
Latest news
Date Title
1m ago BOJ should study shifting focus to zero rates in future - Kiuchi
1m ago Studies from Alnylam Pharmaceuticals in the Area of Herpetology Reported (Mapping Genotype Distributions in the Unisexual Ambystoma Complex)
2m ago CHINA OILFIELD SERVICES : HSBC lifts China Oilfield to HK$25.1
2m ago CULTURECOM : to place up to 157.5m warrants
2m ago CHINA PRECIOUS METAL RESURCS HLDG : CPM to buy investment management & advisory business
2m ago CHINA OCEAN SHIPBUILDING INDUSTRY : Shipbldg places 1.2bn shares for HK$269m
2m ago ICUBE TECHNOLOGY : Tech issues HK$133m CN to buy HK-listed firm
2m ago CHANGFENG AXLE CHINA : to gain Rmb1.89m from sites surrender
3m ago GENWORTH FINANCIAL : In wake of Q2 division earnings, Genworth draws scrutiny
3m ago TOKYO ELECTRIC POWER : Hokkaido Electric seeks to raise electricity bills by around 17%
Latest news
Hot News 
VIROPHARMA : Updated Rule 2.10 Announcement
CLEAN AIR POWER : EPW Subcommittee Hearing Highlights Effects of Climate Change on American Communities
GFI : CME Group and GFI Group Announce Plan for Strategic Transactions
ACTA : Governor Corbett Discusses New Transportation Plan's Role in Maintaining Transit Service for Employees in Pittsburgh Region
Most Read News
5h ago JPMORGAN CHASE : Announces $30 Million for Small Business Network Growth
4h ago AMC NETWORKS : wants stake in BBC America - source
54m ago BANCO MACRO : Argentina fails to reach debt agreement, default imminent
2h ago BANCO ESPIRITO SANTO : BES seeks capital as key staff suspended over massive losses
4h ago MOLECULAR MEDICINE : Researchers from Huazhong University of Science and Technology Provide Details of New Studies and Findings in the Area of Molecular Medicine (Growth...
Most recommended articles
<1m ago BOJ should study shifting focus to zero rates in future - Kiuchi
9m agoDJChina Rundong Seeks to Raise up to $138 Million in IPO
18m agoDJBOJ Board Member Kiuchi Signals Doubts Over Exports
18m agoDJBOE's Broadbent Says Average Rates Over Next Few Years More Important
Dynamic quotes